切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (03) : 288 -293. doi: 10.3877/cma.j.issn.2095-3232.2022.03.015

临床研究

肝移植治疗儿童Abernethy畸形合并肝肺综合征一例并文献复习
赵帅1, 王健1, 韩冰1, 张亦弛1, 丁瀚1, 蔡浩1, 顾劲扬1,()   
  1. 1. 200092 上海交通大学医学院附属新华医院移植科
  • 收稿日期:2022-01-24 出版日期:2022-06-10
  • 通信作者: 顾劲扬
  • 基金资助:
    国家自然科学基金(82130020,82103520,82072646); 促进市级医院临床技能与临床创新能力三年行动计划重大临床研究项目(SHDC2020CR3005A); 上海市教育委员会高峰高原人才计划(20191910); 上海交通大学"医工交叉研究基金"(YG2021QN50)

Liver transplantation for Abernethy malformation complicated with hepatopulmonary syndrome in children: report of one case and literature review

Shuai Zhao1, Jian Wang1, Bing Han1, Yichi Zhang1, Han Ding1, Hao Cai1, Jinyang Gu1,()   

  1. 1. Department of Organ Transplantation, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China
  • Received:2022-01-24 Published:2022-06-10
  • Corresponding author: Jinyang Gu
引用本文:

赵帅, 王健, 韩冰, 张亦弛, 丁瀚, 蔡浩, 顾劲扬. 肝移植治疗儿童Abernethy畸形合并肝肺综合征一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 288-293.

Shuai Zhao, Jian Wang, Bing Han, Yichi Zhang, Han Ding, Hao Cai, Jinyang Gu. Liver transplantation for Abernethy malformation complicated with hepatopulmonary syndrome in children: report of one case and literature review[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(03): 288-293.

目的

探讨儿童Abernethy畸形合并肝肺综合征的诊治。

方法

回顾性分析2020年6月5日在上海交通大学医学院附属新华医院行肝移植治疗的1例儿童Abernethy畸形合并肝肺综合征患者临床资料,并复习相关文献。患儿男,12岁,因"口唇发绀2年,发现肝硬化3个月"入院。肝脏三维重建门静脉示门静脉左、右支及主干近左、右支段严重狭窄。超声心动图示气泡试验阳性。术前诊断:Abernethy畸形,肝纤维化4期,门静脉高压症,肝肺综合征。患儿监护人已签署知情同意书,符合医学伦理学规定。

结果

完善术前准备后行亲体肝移植+脾动脉结扎术。术后采用他克莫司+糖皮质激素免疫抑制治疗。患儿手术成功,肝功能顺利恢复。术后高流量吸氧仪治疗,逐渐下调氧流量及氧浓度。术后2周更换为鼻导管吸氧。术后3周出院,出院后在家鼻导管吸氧,术后5个月脱离吸氧。肝脏病理学检查示弥漫性肝纤维化伴静脉异常改变。

结论

肝移植是治疗儿童Abernethy畸形合并肝肺综合征的有效手段,术前应进行全面评估,术后进行高流量吸氧恢复治疗。

Objective

To investigate the diagnosis and treatments of Abernethy malformation complicated with hepatopulmonary syndrome in children.

Methods

Clinical data of 1 child with Abernethy malformation complicated with hepatopulmonary syndrome who underwent liver transplantation in Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine on June 5, 2020 were retrospectively analyzed. Relevant literature review was performed. A 12-year-old boy was admitted to our hospital due to "perioral cyanosis for 2 years and liver cirrhosis for 3 months". Three-dimensional reconstruction of portal vein showed severe stenosis of the left and right branches of hepatic portal vein and the left and right branches adjacent to the common trunk. Echocardiography showed a positive result for the bubble test. Preoperative diagnosis: Abernethy malformation, stage Ⅳ hepatic fibrosis, portal hypertension and hepatopulmonary syndrome. The informed consents of the guardians of this child were obtained and the local ethical committee approval was received.

Results

After comprehensive preoperative preparations, living related liver transplantation combined with splenic artery ligation were performed. Postoperatively, tacrolimus and glucocorticoid were adopted for immunosuppressive therapy. The child successfully completed the surgery and liver function recovered properly. High-flow oxygen inhalation was performed postoperatively, with gradually declining oxygen flow and concentration, and was changed to nasal cannula oxygen inhalation at 2 weeks after surgery. The child was discharged at postoperative 3 weeks and treated with nasal cannula oxygen inhalation at home, which was removed at 5 months after surgery. Pathological examination of the liver revealed diffuse hepatic fibrosis complicated with abnormal venous changes.

Conclusions

Liver transplantation is an effective treatment for pediatric Abernethy malformation complicated with hepatopulmonary syndrome. Comprehensive preoperative evaluation should be delivered, and high-flow oxygen inhalation can be adoptd after surgery.

图1 一例儿童Abernethy畸形合并肝肺综合征肝脏三维重建注:基于肝脏增强CT采用IQQA-3D软件完成三维重建,示门静脉左、右支及近左、右支的主干段严重狭窄
图2 一例儿童Abernethy畸形合并肝肺综合征患儿母亲供肝三维重建注:基于肝脏增强CT使用IQQA-3D软件完成,示带肝中静脉左半肝供肝,供肝体积468 ml
表1 一例儿童Abernethy畸形合并肝肺综合征患者肝移植术前及脱氧期动脉血气分析结果
[1]
Kumar P, Rao PN. Hepatopulmonary syndrome[J]. N Engl J Med, 2020, 382(10):e14.
[2]
Forde KA, Fallon MB, Krowka MJ, et al. Pulse oximetry is insensitive for detection of hepatopulmonary syndrome in patients evaluated for liver transplantation[J]. Hepatology, 2019, 69(1):270-281.
[3]
Suk KT, Kim MY, Jeong SW, et al. Impact of bacterial translocation on hepatopulmonary syndrome: a prospective observational study[J]. Dig Dis Sci, 2018, 63(1):248-256.
[4]
Zardi EM, Spoto S, Locorriere L, et al. Platypnoea-orthodeoxia syndrome in the elderly: a difficult-to-make diagnosis of intracardiac right-to-left shunt[J]. Scott Med J, 2017, 62(3):122-125.
[5]
El Hadi H, Di Vincenzo A, Vettor R, et al. Relationship between heart disease and liver disease: a two-way street[J]. Cells, 2020, 9(3):567.
[6]
Soulaidopoulos S, Cholongitas E, Giannakoulas G, et al. Review article: update on current and emergent data on hepatopulmonary syndrome[J]. World J Gastroenterol, 2018, 24(12):1285-1298.
[7]
Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis[J]. Liver Int, 2018, 38(4):570-580.
[8]
Lejealle C, Paradis V, Bruno O, et al. Evidence for an association between intrahepatic vascular changes and the development of hepatopulmonary syndrome[J]. Chest, 2019, 155(1):123-136.
[9]
Ceza MR, Garcia E, Anselmi CE, et al. Prevalence and characteristics of hepatopulmonary syndrome in children with cirrhosis in southern Brazil[J]. Eur J Gastroenterol Hepatol, 2019, 31(1):10-15.
[10]
Zhao H, Tsauo J, Zhang XW, et al. Technetium-99m-labeled macroaggregated albumin lung perfusion scan for diagnosis of hepatopulmonary syndrome: a prospective study comparing brain uptake and whole-body uptake[J]. World J Gastroenterol, 2020, 26(10):1088-1097.
[11]
Bernard O, Franchi-Abella S, Branchereau S, et al. Congenital portosystemic shunts in children: recognition, evaluation, and management[J]. Semin Liver Dis, 2012, 32(4):273-287.
[12]
Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder[J]. N Engl J Med, 2008, 358(22):2378-2387.
[13]
Zhang J, Fallon MB. Hepatopulmonary syndrome: update on pathogenesis and clinical features[J]. Nat Rev Gastroenterol Hepatol, 2012, 9(9):539-549.
[14]
Goldberg DS, Krok K, Batra S, et al. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database[J]. Gastroenterology, 2014, 146(5):1256-1265, e1.
[15]
Cywinski JB, Makarova N, Arney A, et al. Resources utilization after liver transplantation in patients with and without hepatopulmonary syndrome: Cleveland clinic experience[J]. Transplant Direct, 2020, 6(4):e545.
[16]
Fuhrmann V, Krowka M. Hepatopulmonary syndrome[J]. J Hepatol. 2018, 69(3):744-745.
[17]
Zardi EM, Giorgi C, Dobrina A, et al. Analogies and differences between cirrhotic cardiomyopathy and hepatopulmonary syndrome[J]. Med Res Rev, 2021, 41(2):739-753.
[18]
Lambert V, Ladarre D, Fortas F, et al. Cardiovascular disorders in patients with congenital portosystemic shunts: 23 years of experience in a tertiary referral centre[J]. Arch Cardiovasc Dis, 2021, 114(3):221-231.
[19]
Peček J, Fister P, Homan M. Abernethy syndrome in Slovenian children: five case reports and review of literature[J]. World J Gastroenterol, 2020, 26(37):5731-5744.
[20]
Baiges A, Turon F, Simón-Talero M, et al. Congenital extrahepatic portosystemic shunts (Abernethy malformation): an international observational study[J]. Hepatology, 2020, 71(2):658-669.
[21]
Nam HD. Living-donor liver transplantation for Abernethy malformation-case report and review of literature[J]. Ann Hepatobiliary Pancreat Surg, 2020, 24(2):203-208.
[22]
Zhang JS, Li L. Surgical ligation of a portosystemic shunt for the treatment of type Ⅱ Abernethy malformation in 12 children[J]. J Vasc Surg Venous Lymphat Disord, 2021, 9(2):444-451.
[23]
Lin Y, Li X, Li S, et al. Treatment option for Abernethy malformation-two cases report and review of the literature[J]. Front Pediatr, 2020(8): 497447.
[24]
Sakamoto S, Shigeta T, Fukuda A, et al. The role of liver transplantation for congenital extrahepatic portosystemic shunt[J]. Transplantation, 2012, 93(12): 1282-1287.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[3] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[7] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[8] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[9] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?